Ikena Oncology Profit Margin 2021-2025 | IMA
Current and historical gross margin, operating margin and net profit margin for Ikena Oncology (IMA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ikena Oncology net profit margin as of March 31, 2025 is 0%.
| Ikena Oncology Annual Profit Margins |
| Ikena Oncology Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.061B |
$0.009B |
|
Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.
|
